Open Pilot Trial of a Mind-body Program for Cardiac Arrest Survivors and Their Caregivers
Launched by MASSACHUSETTS GENERAL HOSPITAL · Jul 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is called "Recovering Together after Cardiac Arrest," and it is designed to help people who have survived a cardiac arrest and their caregivers. The goal of the study is to test a mind-body program that aims to improve emotional well-being for both survivors and their caregivers. Researchers want to learn more about how this program can help reduce feelings of distress and support recovery.
To participate, you need to be a cardiac arrest survivor or a caregiver who provides emotional and functional support to the survivor. You should be at least 18 years old, speak English, and be willing to join sessions either in person or through video or phone calls. The study is looking for participants who may be feeling significant emotional distress, which will be assessed through a simple questionnaire. However, individuals with serious mental health issues, such as active psychosis or suicidal thoughts, cannot take part in the trial. If you join, you can expect to engage in supportive activities that focus on healing and improving emotional health alongside your loved one.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Out-of-hospital or in-hospital CA survivor (must have new diagnosis of "cardiac arrest" in electronic medical record from index hospitalization with documented loss of pulse) with an identified caregiver (identified by the survivor who is their primary source of emotional and functional support)
- • 2. Score ≥4 on Short Form of the Mini Mental State Exam
- • 3. Ability and willingness to participate in a hybrid in-person/live video or phone intervention
- • 4. English speaking adults, 18 years or older
- • 5. At least one member of the dyad endorses clinically significant emotional distress during screening (\>7 on Hospital Anxiety and Depression Scale subscales)
- Exclusion Criteria:
- • 1. Active psychosis, mania, substance dependence, or suicidal intent or plan
About Massachusetts General Hospital
Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Alexander M Presciutti, PhD
Principal Investigator
Massachusetts General Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported